PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $182,000 | -0.5% | 35,800 | -1.3% | 0.01% | 0.0% |
| Q3 2019 | $183,000 | -78.8% | 36,281 | -74.1% | 0.01% | -78.4% |
| Q2 2019 | $863,000 | +22.2% | 139,900 | -8.1% | 0.05% | +27.5% |
| Q1 2019 | $706,000 | +256.6% | 152,200 | +472.1% | 0.04% | +700.0% |
| Q2 2015 | $198,000 | – | 26,606 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|